Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Clinical trial NCT01235754 · COMPLETED
Trial details
- NCT number
- NCT01235754
- Sponsor
- BioSante Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2011-12-01
- Enrollment
- 626
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.